Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aerovate Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12.5K | $205K | $16.37 | Jun 5, 2024 | Direct |
Vor Biopharma Inc. | Director | Stock Option (Right to Buy) | 30K | May 23, 2024 | Direct | ||
PepGen Inc. | Director | Stock Option (Right to Buy) | 13K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PEPG | PepGen Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
VOR | Vor Biopharma Inc. | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | Director |
PEPG | PepGen Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
VOR | Vor Biopharma Inc. | May 26, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
VOR | Vor Biopharma Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
PEPG | PepGen Inc. | May 6, 2022 | 1 | $0 | 4 | May 10, 2022 | Director |
PEPG | PepGen Inc. | May 5, 2022 | 0 | $0 | 3 | May 5, 2022 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jun 29, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jun 29, 2021 | 0 | $0 | 3 | Jun 29, 2021 | Director |